Abstract:Low-risk human papillomaviruses (LR-HPVs) are the causative agents of genital warts, which are a widespread sexually transmitted disease. How LR-HPVs affect autophagy and the specific proteins involved are unknown. In the current study, we investigated the impact of LR-HPV11 early protein 6 (E6) on the activity of the autophagy pathway. We transfected an HPV11 E6 (11E6) plasmid into HaCaT cells, H8 cells, and NHEK cells and established a stable cell line expressing the HPV11 E6 protein. The differences in autophagy activity and upstream regulatory pathways compared with those in the parent cell lines were investigated using a Western blot analysis of the total and phosphorylated protein levels and confocal microscopy of immunostained cells and cells transfected with an mCherry-green fluorescent protein-LC3 expression plasmid. We used short hairpin RNA (shRNA) to knock down 11E6 and showed that these effects require continued 11E6 expression. Compared with its expression in the control cells, the expression of HPV11 E6 in the cells activated the autophagy pathway. The increased autophagy activity was the result of the decreased phosphorylation levels of the canonical autophagy repressor mammalian target of rapamycin (mTOR) at its Ser2448 position (the mTOR complex 1 [mTORC1] phosphorylation site) and decreased AKT and Erk phosphorylation. Therefore, these results indicate that HPV11 E6 activates autophagy through the AKT/mTOR and Erk/mTOR pathways. Our findings provide novel insight into the relationship between LR-HPV infections and autophagy and could help elucidate the pathogenic mechanisms of LR-HPV.IMPORTANCE We transfected an HPV11 E6 plasmid into HaCaT cells, H8 cells, and NHEK cells and established a stable cell line expressing the HPV11 E6 protein. Then, we confirmed that HPV11 E6 induces autophagy by suppressing the AKT/mTOR and Erk/mTOR pathways. In contrast to the high-risk HPV E6 genes, HPV11 E6 did not affect the expression of p53. To the best of our knowledge, this study represents the first direct in-depth investigation of the relationship between the LR-HPV E6 gene and autophagy, which may help to reveal the pathogenesis of LR-HPV infection.

Human Papilloma Virus and Autophagy

Advances on Autophagy and Human Papillomavirus

Relationship of Autophagy Genes and Human Papillomavirus Infection

Ubiquitination in Host Immune Response to Human Papillomavirus Infection

Autophagy is Induced in Human Keratinocytes During Human Papillomavirus 11 Pseudovirion Entry

Human Papillomavirus 11 Early Protein E6 Activates Autophagy by Repressing AKT/mTOR and Erk/mTOR

Engagement of Programmed Cell Death 1 and Its Ligands in Human Papillomaviurs Related Diseases

The dual role of autophagy in HPV-positive head and neck squamous cell carcinoma: a systematic review

Human papillomavirus infection and host innate immune responses

Digital RNA Sequencing of Human Epidermal Keratinocytes Carrying Human Papillomavirus Type 16 E7

Reduced Expression of Autophagy Markers Correlates with High-Risk Human Papillomavirus Infection in Human Cervical Squamous Cell Carcinoma

Human papillomavirus molecular biology and disease association

Human Papillomavirus Type 16 Early Protein E7 Activates Autophagy Through Inhibition of Dual-Specificity Phosphatase 5

Human Papillomaviruses Target the DNA Damage Repair and Innate Immune Response Pathways to Allow for Persistent Infection

Human Papillomavirus 16E6/E7 Activates Autophagy Via Atg9B and LAMP1 in Cervical Cancer Cells

Pathogenesis of Human Papillomaviruses Requires the ATR/p62 Autophagy-Related Pathway

Human Oncogenic Viruses: Characteristics and Prevention Strategies—Lessons Learned from Human Papillomaviruses

Unveiling the multifaceted realm of human papillomavirus: a comprehensive exploration of biology, interactions, and advances in cancer management

How Human Papillomavirus Replication and Immune Evasion Strategies Take Advantage of the Host DNA Damage Repair Machinery

HPV-driven oncogenesis—much more than the E6 and E7 oncoproteins

Human Papillomavirus and the Development of Different Cancers